Search

Artificial intelligence (AI) algorithms are playing a crucial role in transforming healthcare by enhancing the quality, accessibility, and efficiency of medical care, research, and operations. These algorithms enable healthcare providers to offer more accurate diagnoses, predict outcomes, and customize treatments to individual patient needs. AI also improves operational efficiency by automating routine tasks and optimizing resource management. However, there are challenges to adopting AI in healthcare, such as data privacy concerns and potential biases in algorithms. Collaboration among stakeholders is necessary to ensure ethical use of AI and its positive impact on the field. AI also has applications in medical research, preventive medicine, and public health. It is important to recognize that AI should augment, not replace, the expertise and compassionate care provided by healthcare professionals. The ethical implications and societal impact of AI in healthcare must be carefully considered, guided by fairness, transparency, and accountability principles. Several research papers in this special issue explore the application of AI algorithms in various aspects of healthcare, such as gait analysis for Parkinson's disease diagnosis, human activity recognition, heart disease prediction, compliance assessment with clinical protocols, epidemic management, neurological complications identification, fall prevention, leukemia diagnosis, and genetic clinical pathways. These studies demonstrate the potential of AI in improving medical diagnostics, patient monitoring, and personalized care. [Extracted from the article]

Deep reinforcement learning is an artificial intelligence technology that combines deep learning and reinforcement learning and has been widely applied in multiple fields. As a type of deep reinforcement learning algorithm, the A3C (Asynchronous Advantage Actor-Critic) algorithm can effectively utilize computer resources and improve training efficiency by synchronously training Actor-Critic in multiple threads. Inspired by the excellent performance of the A3C algorithm, this paper uses the A3C algorithm to solve the UUV (Unmanned Underwater Vehicle) collision avoidance planning problem in unknown environments. This collision avoidance planning algorithm can have the ability to plan in real-time while ensuring a shorter path length, and the output action space can meet the kinematic constraints of UUVs. In response to the problem of UUV collision avoidance planning, this paper designs the state space, action space, and reward function. The simulation results show that the A3C collision avoidance planning algorithm can guide a UUV to avoid obstacles and reach the preset target point. The path planned by this algorithm meets the heading constraints of the UUV, and the planning time is short, which can meet the requirements of real-time planning. [ABSTRACT FROM AUTHOR]

Given the increasingly important role that the use of artificial intelligence algorithms is taking on in the medical field today (especially in oncology), the purpose of this systematic review is to analyze the main reports on such algorithms applied for the prognostic evaluation of patients with head and neck malignancies. The objective of this paper is to examine the currently available literature in the field of artificial intelligence applied to head and neck oncology, particularly in the prognostic evaluation of the patient with this kind of tumor, by means of a systematic review. The paper exposes an overview of the applications of artificial intelligence in deriving prognostic information related to the prediction of survival and recurrence and how these data may have a potential impact on the choice of therapeutic strategy, making it increasingly personalized. This systematic review was written following the PRISMA 2020 guidelines. [ABSTRACT FROM AUTHOR]

Simple Summary: Risk assessment in early breast cancer is critical for clinical decisions, but defining risk categories poses a significant challenge. The integration of conventional histopathology and biomarkers with artificial intelligence (AI) techniques, including machine learning and deep learning, has the potential to offer more precise information. AI applications extend beyond detection to histological subtyping, grading, and molecular feature identification. The successful integration of AI into clinical practice requires collaboration between histopathologists, molecular pathologists, computational pathologists, and oncologists to optimize patient outcomes. Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopathological, immunohistochemical, and molecular biomarkers alongside cutting-edge artificial intelligence (AI) techniques. Leveraging machine learning, deep learning, and convolutional neural networks, AI is reshaping predictive algorithms for recurrence risk, thereby revolutionizing diagnostic accuracy and treatment planning. Beyond detection, AI applications extend to histological subtyping, grading, lymph node assessment, and molecular feature identification, fostering personalized therapy decisions. With rising cancer rates, it is crucial to implement AI to accelerate breakthroughs in clinical practice, benefiting both patients and healthcare providers. However, it is important to recognize that while AI offers powerful automation and analysis tools, it lacks the nuanced understanding, clinical context, and ethical considerations inherent to human pathologists in patient care. Hence, the successful integration of AI into clinical practice demands collaborative efforts between medical experts and computational pathologists to optimize patient outcomes. [ABSTRACT FROM AUTHOR]

In recent times, there has been considerable focus on harnessing artificial intelligence (AI) for medical image analysis and healthcare purposes. In this study, we introduce CADFU (Computer-Aided Diagnosis System for Foot Ulcers), a pioneering diabetic foot ulcer diagnosis system. The primary objective of CADFU is to detect and segment ulcers and similar chronic wounds in medical images. To achieve this, we employ two distinct algorithms. Firstly, DHuNeT, an innovative Dual-Phase Hyperactive UNet, is utilized for the segmentation task. Second, we used YOLOv8 for the task of detecting wounds. The DHuNeT autoencoder, employed for the wound segmentation task, is the paper's primary and most significant contribution. DHuNeT is the combination of sequentially stacking two UNet autoencoders. The hyperactive information transmission from the first UNet to the second UNet is the key idea of DHuNeT. The first UNet feeds the second UNet the features it has learned, and the two UNets combine their learned features to create new, more accurate, and effective features. We achieve good performance measures, especially in terms of the Dice co-efficient and precision, with segmentation scores of 85% and 92.6%, respectively. We obtain a mean average precision (mAP) of 86% in the detection task. Future hospitals could quickly monitor patients' health using the proposed CADFU system, which would be beneficial for both patients and doctors. [ABSTRACT FROM AUTHOR]

Simple Summary: Melanoma is the most dangerous type of skin cancer worldwide. Early detection of melanoma is crucial for better outcomes, but this often can be challenging. This research explores the use of artificial intelligence (AI) techniques combined with non-invasive imaging methods to improve melanoma detection. The authors aim to evaluate the current state of AI-based techniques using tools including dermoscopy, optical coherence tomography (OCT), and reflectance confocal microscopy (RCM). The findings demonstrate that several AI algorithms perform as well as or better than dermatologists in detecting melanoma, particularly in the analysis of dermoscopy images. This research highlights the potential of AI to enhance diagnostic accuracy, leading to improved patient outcomes. Further studies are needed to address limitations and ensure the reliability and effectiveness of AI-based techniques. Background: Melanoma, the deadliest form of skin cancer, poses a significant public health challenge worldwide. Early detection is crucial for improved patient outcomes. Non-invasive skin imaging techniques allow for improved diagnostic accuracy; however, their use is often limited due to the need for skilled practitioners trained to interpret images in a standardized fashion. Recent innovations in artificial intelligence (AI)-based techniques for skin lesion image interpretation show potential for the use of AI in the early detection of melanoma. Objective: The aim of this study was to evaluate the current state of AI-based techniques used in combination with non-invasive diagnostic imaging modalities including reflectance confocal microscopy (RCM), optical coherence tomography (OCT), and dermoscopy. We also aimed to determine whether the application of AI-based techniques can lead to improved diagnostic accuracy of melanoma. Methods: A systematic search was conducted via the Medline/PubMed, Cochrane, and Embase databases for eligible publications between 2018 and 2022. Screening methods adhered to the 2020 version of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Included studies utilized AI-based algorithms for melanoma detection and directly addressed the review objectives. Results: We retrieved 40 papers amongst the three databases. All studies directly comparing the performance of AI-based techniques with dermatologists reported the superior or equivalent performance of AI-based techniques in improving the detection of melanoma. In studies directly comparing algorithm performance on dermoscopy images to dermatologists, AI-based algorithms achieved a higher ROC (>80%) in the detection of melanoma. In these comparative studies using dermoscopic images, the mean algorithm sensitivity was 83.01% and the mean algorithm specificity was 85.58%. Studies evaluating machine learning in conjunction with OCT boasted accuracy of 95%, while studies evaluating RCM reported a mean accuracy rate of 82.72%. Conclusions: Our results demonstrate the robust potential of AI-based techniques to improve diagnostic accuracy and patient outcomes through the early identification of melanoma. Further studies are needed to assess the generalizability of these AI-based techniques across different populations and skin types, improve standardization in image processing, and further compare the performance of AI-based techniques with board-certified dermatologists to evaluate clinical applicability. [ABSTRACT FROM AUTHOR]

Data-driven algorithms have proven to be effective for a variety of medical tasks, including disease categorization and prediction, personalized medicine design, and imaging diagnostics. Although their performance is frequently on par with that of clinicians, their widespread use is constrained by a number of obstacles, including the requirement for high-quality data that are typical of the population, the difficulty of explaining how they operate, and ethical and regulatory concerns. The use of data augmentation and synthetic data generation methodologies, such as federated learning and explainable artificial intelligence ones, could provide a viable solution to the current issues, facilitating the widespread application of artificial intelligence algorithms in the clinical application domain and reducing the time needed for prevention, diagnosis, and prognosis by up to 70%. To this end, a novel AI-based functional framework is conceived and presented in this paper. [ABSTRACT FROM AUTHOR]

Simple Summary: Accurately grading gliomas, which are the most common and aggressive malignant brain tumors in adults, poses a significant challenge for radiologists. This study explores the application of Deep Learning techniques in assisting tumor grading using Magnetic Resonance Images (MRIs). By analyzing a glioma database sourced from multiple public datasets and comparing different settings, the aim of this study is to develop a robust and reliable grading system. The study demonstrates that by focusing on the tumor region of interest and augmenting the available data, there is a significant improvement in both the accuracy and confidence of tumor grade classifications. While successful in differentiating low-grade gliomas from high-grade gliomas, the accurate classification of grades 2, 3, and 4 remains challenging. The research findings have significant implications for advancing the development of a non-invasive, robust, and trustworthy data-driven system to support clinicians in the diagnosis and therapy planning of glioma patients. Glioma is the most common type of tumor in humans originating in the brain. According to the World Health Organization, gliomas can be graded on a four-stage scale, ranging from the most benign to the most malignant. The grading of these tumors from image information is a far from trivial task for radiologists and one in which they could be assisted by machine-learning-based decision support. However, the machine learning analytical pipeline is also fraught with perils stemming from different sources, such as inadvertent data leakage, adequacy of 2D image sampling, or classifier assessment biases. In this paper, we analyze a glioma database sourced from multiple datasets using a simple classifier, aiming to obtain a reliable tumor grading and, on the way, we provide a few guidelines to ensure such reliability. Our results reveal that by focusing on the tumor region of interest and using data augmentation techniques we significantly enhanced the accuracy and confidence in tumor classifications. Evaluation on an independent test set resulted in an AUC-ROC of 0.932 in the discrimination of low-grade gliomas from high-grade gliomas, and an AUC-ROC of 0.893 in the classification of grades 2, 3, and 4. The study also highlights the importance of providing, beyond generic classification performance, measures of how reliable and trustworthy the model's output is, thus assessing the model's certainty and robustness. [ABSTRACT FROM AUTHOR]

Due to the daily use of mobile technologies, we live in constant connection with the world through the Internet. Technological innovations in smart devices have allowed us to carry out everyday activities such as communicating, working, studying or using them as a means of entertainment, which has led to smartphones displacing computers as the most important device connected to the Internet today, causing users to demand smarter applications or functionalities that allow them to meet their needs. Artificial intelligence has been a major innovation in information technology that is transforming the way users use smart devices. Using applications that make use of artificial intelligence has revolutionised our lives, from making predictions of possible words based on typing in a text box, to being able to unlock devices through pattern recognition. However, these technologies face problems such as overheating and battery drain due to high resource consumption, low computational capacity, memory limitations, etc. This paper reviews the most important artificial intelligence algorithms for mobile devices, emphasising the challenges and problems that can arise when implementing these technologies in low-resource devices. [ABSTRACT FROM AUTHOR]

Quality inspection in the industrial production field is experiencing a strong technological development that benefits from the combination of vision-based techniques with artificial intelligence algorithms. This paper initially addresses the problem of defect identification for circularly symmetric mechanical components, characterized by the presence of periodic elements. In the specific case of knurled washers, we compare the performances of a standard algorithm for the analysis of grey-scale image with a Deep Learning (DL) approach. The standard algorithm is based on the extraction of pseudo-signals derived from the conversion of the grey scale image of concentric annuli. In the DL approach, the component inspection is shifted from the entire sample to specific areas repeated along the object profile where the defect may occur. The standard algorithm provides better results in terms of accuracy and computational time with respect to the DL approach. Nevertheless, DL reaches accuracy higher than 99% when performance is evaluated targeting the identification of damaged teeth. The possibility of extending the methods and the results to other circularly symmetrical components is analyzed and discussed. [ABSTRACT FROM AUTHOR]

Simple Summary: Artificial intelligence techniques have changed the traditional way of diagnosis. The physicians' consultation decisions can now be supported with a particular algorithm that is beneficial for the patient in terms of accuracy and time saved. Many deep learning and machine learning algorithms are being validated and tested regularly; still, only a few can be implemented clinically. This review aims to shed light on the current and potential applications of deep learning and machine learning in tumor pathology. The revolution of artificial intelligence and its impacts on our daily life has led to tremendous interest in the field and its related subtypes: machine learning and deep learning. Scientists and developers have designed machine learning- and deep learning-based algorithms to perform various tasks related to tumor pathologies, such as tumor detection, classification, grading with variant stages, diagnostic forecasting, recognition of pathological attributes, pathogenesis, and genomic mutations. Pathologists are interested in artificial intelligence to improve the diagnosis precision impartiality and to minimize the workload combined with the time consumed, which affects the accuracy of the decision taken. Regrettably, there are already certain obstacles to overcome connected to artificial intelligence deployments, such as the applicability and validation of algorithms and computational technologies, in addition to the ability to train pathologists and doctors to use these machines and their willingness to accept the results. This review paper provides a survey of how machine learning and deep learning methods could be implemented into health care providers' routine tasks and the obstacles and opportunities for artificial intelligence application in tumor morphology. [ABSTRACT FROM AUTHOR]

Machine learning technologies are being integrated into robotic systems faster to enhance their efficacy and adaptability in dynamic environments. The primary goal of this research was to propose a method to develop an Autonomous Mobile Robot (AMR) that integrates Simultaneous Localization and Mapping (SLAM), odometry, and artificial vision based on deep learning (DL). All are executed on a high-performance Jetson Nano embedded system, specifically emphasizing SLAM-based obstacle avoidance and path planning using the Adaptive Monte Carlo Localization (AMCL) algorithm. Two Convolutional Neural Networks (CNNs) were selected due to their proven effectiveness in image and pattern recognition tasks. The ResNet18 and YOLOv3 algorithms facilitate scene perception, enabling the robot to interpret its environment effectively. Both algorithms were implemented for real-time object detection, identifying and classifying objects within the robot's environment. These algorithms were selected to evaluate their performance metrics, which are critical for real-time applications. A comparative analysis of the proposed DL models focused on enhancing vision systems for autonomous mobile robots. Several simulations and real-world trials were conducted to evaluate the performance and adaptability of these models in navigating complex environments. The proposed vision system with CNN ResNet18 achieved an average accuracy of 98.5%, a precision of 96.91%, a recall of 97%, and an F1-score of 98.5%. However, the YOLOv3 model achieved an average accuracy of 96%, a precision of 96.2%, a recall of 96%, and an F1-score of 95.99%. These results underscore the effectiveness of the proposed intelligent algorithms, robust embedded hardware, and sensors in robotic applications. This study proves that advanced DL algorithms work well in robots and could be used in many fields, such as transportation and assembly. As a consequence of the findings, intelligent systems could be implemented more widely in the operation and development of AMRs. [ABSTRACT FROM AUTHOR]

Simple Summary: Early characterization of the isocitrate dehydrogenase (IDHIDH) gene mutation status of glioma is crucial for personalized decision making and prognosis in clinical neurooncological treatment. Based on the known differences in energy metabolism between IDHIDH-mutated and IDHIDH-wildtype gliomas, we assessed physio-metabolic magnetic resonance imaging-based measures along with machine learning for potential reliable presurgical characterization of IDHIDH gene status. Traditional machine learning algorithms and simple deep learning models trained in analyzing physio-metabolic parameters demonstrated the best performance in classifying the IDHIDH gene status of gliomas in independent internal testing. In contrast, external testing revealed that traditional machine learning models trained on clinical MRI data had higher accuracy compared to physio-metabolic algorithms, reflecting differences in data acquisition methodology between the two sites. Our results outline the necessity of independent internal and external testing, thus calling for standardized and robust protocols for clinical MRI-driven AI applications. The mutational status of the isocitrate dehydrogenase (IDH) gene plays a key role in the treatment of glioma patients because it is known to affect energy metabolism pathways relevant to glioma. Physio-metabolic magnetic resonance imaging (MRI) enables the non-invasive analysis of oxygen metabolism and tissue hypoxia as well as associated neovascularization and microvascular architecture. However, evaluating such complex neuroimaging data requires computational support. Traditional machine learning algorithms and simple deep learning models were trained with radiomic features from clinical MRI (cMRI) or physio-metabolic MRI data. A total of 215 patients (first center: 166 participants + 16 participants for independent internal testing of the algorithms versus second site: 33 participants for independent external testing) were enrolled using two different physio-metabolic MRI protocols. The algorithms trained with physio-metabolic data demonstrated the best classification performance in independent internal testing: precision, 91.7%; accuracy, 87.5%; area under the receiver operating curve (AUROC), 0.979. In external testing, traditional machine learning models trained with cMRI data exhibited the best IDH classification results: precision, 84.9%; accuracy, 81.8%; and AUROC, 0.879. The poor performance for the physio-metabolic MRI approach appears to be explainable by site-dependent differences in data acquisition methodologies. The physio-metabolic MRI approach potentially supports reliable classification of IDH gene status in the presurgical stage of glioma patients. However, non-standardized protocols limit the level of evidence and underlie the need for a reproducible framework of data acquisition techniques. [ABSTRACT FROM AUTHOR]

Simple Summary: Artificial intelligence (AI) is gaining more and more attention in radiology. The efficiency of AI-based algorithms to solve specific problems is, in some cases, far superior compared to human-driven approaches. This is particularly evident in some repetitive tasks, such as segmentation, where AI usually outperforms manual approaches. AI may be also used in quantification where it can provide, for example, fast and efficient longitudinal follow up in liver tumour burden. AI, thanks to the association with radiomic and big data, may also suggest a diagnosis. Finally, AI algorithms can also reduce scan time, increase image quality and, in the case of computed tomography, reduce patient dose. Artificial intelligence (AI) is one of the most promising fields of research in medical imaging so far. By means of specific algorithms, it can be used to help radiologists in their routine workflow. There are several papers that describe AI approaches to solve different problems in liver and pancreatic imaging. These problems may be summarized in four different categories: segmentation, quantification, characterization and image quality improvement. Segmentation is usually the first step of successive elaborations. If done manually, it is a time-consuming process. Therefore, the semi-automatic and automatic creation of a liver or a pancreatic mask may save time for other evaluations, such as quantification of various parameters, from organs volume to their textural features. The alterations of normal liver and pancreas structure may give a clue to the presence of a diffuse or focal pathology. AI can be trained to recognize these alterations and propose a diagnosis, which may then be confirmed or not by radiologists. Finally, AI may be applied in medical image reconstruction in order to increase image quality, decrease dose administration (referring to computed tomography) and reduce scan times. In this article, we report the state of the art of AI applications in these four main categories. [ABSTRACT FROM AUTHOR]

Artificial intelligence (AI) has emerged as a crucial tool in healthcare with the primary aim of improving patient outcomes and optimizing healthcare delivery. By harnessing machine learning algorithms, natural language processing, and computer vision, AI enables the analysis of complex medical data. The integration of AI into healthcare systems aims to support clinicians, personalize patient care, and enhance population health, all while addressing the challenges posed by rising costs and limited resources. As a subdivision of computer science, AI focuses on the development of advanced algorithms capable of performing complex tasks that were once reliant on human intelligence. The ultimate goal is to achieve human-level performance with improved efficiency and accuracy in problem-solving and task execution, thereby reducing the need for human intervention. Various industries, including engineering, media/entertainment, finance, and education, have already reaped significant benefits by incorporating AI systems into their operations. Notably, the healthcare sector has witnessed rapid growth in the utilization of AI technology. Nevertheless, there remains untapped potential for AI to truly revolutionize the industry. It is important to note that despite concerns about job displacement, AI in healthcare should not be viewed as a threat to human workers. Instead, AI systems are designed to augment and support healthcare professionals, freeing up their time to focus on more complex and critical tasks. By automating routine and repetitive tasks, AI can alleviate the burden on healthcare professionals, allowing them to dedicate more attention to patient care and meaningful interactions. However, legal and ethical challenges must be addressed when embracing AI technology in medicine, alongside comprehensive public education to ensure widespread acceptance. [ABSTRACT FROM AUTHOR]

Simple Summary: In this comprehensive review, we aimed to summarize the advances made by artificial intelligence in the field of lung cancer screening, diagnosis, and management. We now understand the utility of AI as a tool that can supplement physicians to improve the quality of care provided, which is the core message of this review, along with the relevant literature supporting the advances. Lung cancer remains one of the leading causes of cancer-related deaths worldwide, emphasizing the need for improved diagnostic and treatment approaches. In recent years, the emergence of artificial intelligence (AI) has sparked considerable interest in its potential role in lung cancer. This review aims to provide an overview of the current state of AI applications in lung cancer screening, diagnosis, and treatment. AI algorithms like machine learning, deep learning, and radiomics have shown remarkable capabilities in the detection and characterization of lung nodules, thereby aiding in accurate lung cancer screening and diagnosis. These systems can analyze various imaging modalities, such as low-dose CT scans, PET-CT imaging, and even chest radiographs, accurately identifying suspicious nodules and facilitating timely intervention. AI models have exhibited promise in utilizing biomarkers and tumor markers as supplementary screening tools, effectively enhancing the specificity and accuracy of early detection. These models can accurately distinguish between benign and malignant lung nodules, assisting radiologists in making more accurate and informed diagnostic decisions. Additionally, AI algorithms hold the potential to integrate multiple imaging modalities and clinical data, providing a more comprehensive diagnostic assessment. By utilizing high-quality data, including patient demographics, clinical history, and genetic profiles, AI models can predict treatment responses and guide the selection of optimal therapies. Notably, these models have shown considerable success in predicting the likelihood of response and recurrence following targeted therapies and optimizing radiation therapy for lung cancer patients. Implementing these AI tools in clinical practice can aid in the early diagnosis and timely management of lung cancer and potentially improve outcomes, including the mortality and morbidity of the patients. [ABSTRACT FROM AUTHOR]

Artificial intelligence (AI) acts as a vital part of enhancing network security using intrusion detection and anomaly detection. These AI-driven approaches have become essential components of modern cybersecurity strategies. Conventional IDS is based on predefined signatures of known attacks. AI improves signature-based detection by automating the signature generation and reducing false positives through pattern recognition. It can automate threat detection and response, allowing for faster reaction times and reducing the burden on human analysts. With this motivation, this study introduces an Improved Sine Cosine Algorithm with a Deep Learning-Enabled Security Solution (ISCA-DLESS) technique. The presented ISCA-DLESS technique relies on metaheuristic-based feature selection (FS) and a hyperparameter tuning process. In the presented ISCA-DLESS technique, the FS technique using ISCA is applied. For the detection of anomalous activities or intrusions, the multiplicative long short-term memory (MLSTM) approach is used. For improving the anomaly detection rate of the MLSTM approach, the fruitfly optimization (FFO) algorithm can be utilized for the hyperparameter tuning process. The simulation value of the ISCA-DLESS approach was tested on a benchmark NSL-KDD database. The extensive comparative outcomes demonstrate the enhanced solution of the ISCA-DLESS system with other recent systems with a maximum accuracy of 99.69%. [ABSTRACT FROM AUTHOR]

The purpose of this study is to explore how machine learning technologies can improve healthcare operations management. A machine learning-based model to solve a specific medical problem is developed to achieve this research purpose. Specifically, this study presents an AI solution for malaria infection diagnosis by applying the CNN (convolutional neural network) algorithm. Based on malaria microscopy image data from the NIH National Library of Medicine, a total of 24,958 images were used for deep learning training, and 2600 images were selected for final testing of the proposed diagnostic architecture. The empirical results indicate that the CNN diagnostic model correctly classified most malaria-infected and non-infected cases with minimal misclassification, with performance metrics of precision (0.97), recall (0.99), and f1-score (0.98) for uninfected cells, and precision (0.99), recall (0.97), and f1-score (0.98) for parasite cells. The CNN diagnostic solution rapidly processed a large number of cases with a high reliable accuracy of 97.81%. The performance of this CNN model was further validated through the k-fold cross-validation test. These results suggest the advantage of machine learning-based diagnostic methods over conventional manual diagnostic methods in improving healthcare operational capabilities in terms of diagnostic quality, processing costs, lead time, and productivity. In addition, a machine learning diagnosis system is more likely to enhance the financial profitability of healthcare operations by reducing the risk of unnecessary medical disputes related to diagnostic errors. As an extension for future research, propositions with a research framework are presented to examine the impacts of machine learning on healthcare operations management for safety and quality of life in global communities. [ABSTRACT FROM AUTHOR]

The advent of artificial intelligence (AI), especially the state-of-the-art deep learning frameworks, has begun a silent revolution in all medical subfields, including ophthalmology. Due to their specific microvascular and neural structures, the eyes are anatomically associated with the rest of the body. Hence, ocular image-based AI technology may be a useful alternative or additional screening strategy for systemic diseases, especially where resources are scarce. This review summarizes the current applications of AI related to the prediction of systemic diseases from multimodal ocular images, including cardiovascular diseases, dementia, chronic kidney diseases, and anemia. Finally, we also discuss the current predicaments and future directions of these applications. [ABSTRACT FROM AUTHOR]

Several malware variants have attacked systems and data over time. Ransomware is among the most harmful malware since it causes huge losses. In order to get a ransom, ransomware is software that locks the victim's machine or encrypts his personal information. Numerous research has been conducted to stop and quickly recognize ransomware attacks. For proactive forecasting, artificial intelligence (AI) techniques are used. Traditional machine learning/deep learning (ML/DL) techniques, however, take a lot of time and decrease the accuracy and latency performance of network monitoring. In this study, we utilized the Hoeffding trees classifier as one of the stream data mining classification techniques to detect and prevent ransomware attacks. Three Hoeffding trees classifier algorithms are selected to be applied to the Resilient Information Systems Security (RISS) research group dataset. After configuration, Massive Online Analysis (MOA) software is utilized as a testing framework. The results of Hoeffding tree classifier algorithms are then assessed to choose the enhanced model with the highest accuracy and latency performance. In conclusion, the 99.41% classification accuracy was the highest result achieved by the EFDT algorithm in 66 ms. [ABSTRACT FROM AUTHOR]

Simple Summary: Breast cancer affects millions of women worldwide. We aim to provide radiologists with automatic support for mammography review. We propose deploying deep learning models with Multiple Instance Learning algorithms for breast cancer diagnosis (cancer versus non-cancer classification) based on digital mammography images, taking advantage of data annotated at an image level without indicating where the lesion is. We employed algorithms to analyse original, high-resolution images with minimal reduction in size. We used graphical suggestions of attentional maps to verify the correctness of the algorithm and to indicate the areas of the images where cancer lesions are. Finally, we performed comparative and validation studies on external datasets differing in the number of images, pixel intensity levels, and subtypes of existing lesions, showing high accuracy and potential for generalisability of the algorithms. Breast cancer is the most frequent female cancer, with a considerable disease burden and high mortality. Early diagnosis with screening mammography might be facilitated by automated systems supported by deep learning artificial intelligence. We propose a model based on a weakly supervised Clustering-constrained Attention Multiple Instance Learning (CLAM) classifier able to train under data scarcity effectively. We used a private dataset with 1174 non-cancer and 794 cancer images labelled at the image level with pathological ground truth confirmation. We used feature extractors (ResNet-18, ResNet-34, ResNet-50 and EfficientNet-B0) pre-trained on ImageNet. The best results were achieved with multimodal-view classification using both CC and MLO images simultaneously, resized by half, with a patch size of 224 px and an overlap of 0.25. It resulted in AUC-ROC = 0.896 ± 0.017, F1-score 81.8 ± 3.2, accuracy 81.6 ± 3.2, precision 82.4 ± 3.3, and recall 81.6 ± 3.2. Evaluation with the Chinese Mammography Database, with 5-fold cross-validation, patient-wise breakdowns, and transfer learning, resulted in AUC-ROC 0.848 ± 0.015, F1-score 78.6 ± 2.0, accuracy 78.4 ± 1.9, precision 78.8 ± 2.0, and recall 78.4 ± 1.9. The CLAM algorithm's attentional maps indicate the features most relevant to the algorithm in the images. Our approach was more effective than in many other studies, allowing for some explainability and identifying erroneous predictions based on the wrong premises. [ABSTRACT FROM AUTHOR]

People in the life sciences who work with Artificial Intelligence (AI) and Machine Learning (ML) are under increased pressure to develop algorithms faster than ever. The possibility of revealing innovative insights and speeding breakthroughs lies in using large datasets integrated on several levels. However, even if there is more data at our disposal than ever, only a meager portion is being filtered, interpreted, integrated, and analyzed. The subject of this technology is the study of how computers may learn from data and imitate human mental processes. Both an increase in the learning capacity and the provision of a decision support system at a size that is redefining the future of healthcare are enabled by AI and ML. This article offers a survey of the uses of AI and ML in the healthcare industry, with a particular emphasis on clinical, developmental, administrative, and global health implementations to support the healthcare infrastructure as a whole, along with the impact and expectations of each component of healthcare. Additionally, possible future trends and scopes of the utilization of this technology in medical infrastructure have also been discussed. [ABSTRACT FROM AUTHOR]

Artificial intelligence (AI) algorithms can provide actionable insights for clinical decision-making and managing chronic diseases. The treatment and management of complex chronic diseases, such as diabetes, stands to benefit from novel AI algorithms analyzing the frequent real-time streaming data and the occasional medical diagnostics and laboratory test results reported in electronic health records (EHR). Novel algorithms are needed to develop trustworthy, responsible, reliable, and robust AI techniques that can handle the imperfect and imbalanced data of EHRs and inconsistencies or discrepancies with free-living self-reported information. The challenges and applications of AI for two problems in the healthcare domain were explored in this work. First, we introduced novel AI algorithms for EHRs designed to be fair and unbiased while accommodating privacy concerns in predicting treatments and outcomes. Then, we studied the innovative approach of using machine learning to improve automated insulin delivery systems through analyzing real-time information from wearable devices and historical data to identify informative trends and patterns in free-living data. Application examples in the treatment of diabetes demonstrate the benefits of AI tools for medical and health informatics. [ABSTRACT FROM AUTHOR]

Simple Summary: The rapid development of technology has enabled numerous applications of artificial intelligence (AI), especially in medical science. Histopathological assessment of tissues remains the gold standard for diagnosis of gastrointestinal (GI) cancers for subsequent management. In a traditional anatomical pathology (AP) laboratory, histopathologists are required to manually assess, quantify and classify diseases under a microscope in a semiquantitative or qualitative manner. The conversion of analogue-to-digital pathology is on the rise, conforming with trends toward digitalization. The rapid adoption of digital pathology (DP) is driven by factors such as the worldwide shortage of pathologists and medical technologists, the increasing incidence of cancer and the critical need to improve laboratory efficiency. In this review, we aim to provide a comprehensive summary of algorithms for AI detection and classification of GI cancer. We will also provide critical insight into the application of algorithms for routine care in clinical practice. The implementation of DP will revolutionize current practice by providing pathologists with additional tools and algorithms to improve workflow. Furthermore, DP will open up opportunities for development of AI-based tools for more precise and reproducible diagnosis through computational pathology. One of the key features of AI is its capability to generate perceptions and recognize patterns beyond the human senses. Thus, the incorporation of AI into DP can reveal additional morphological features and information. At the current rate of AI development and adoption of DP, the interest in computational pathology is expected to rise in tandem. There have already been promising developments related to AI-based solutions in prostate cancer detection; however, in the GI tract, development of more sophisticated algorithms is required to facilitate histological assessment of GI specimens for early and accurate diagnosis. In this review, we aim to provide an overview of the current histological practices in AP laboratories with respect to challenges faced in image preprocessing, present the existing AI-based algorithms, discuss their limitations and present clinical insight with respect to the application of AI in early detection and diagnosis of GI cancer. [ABSTRACT FROM AUTHOR]

Effective screening provides efficient and quick diagnoses of COVID-19 and could alleviate related problems in the health care system. A prediction model that combines multiple features to assess contamination risks was established in the hope of supporting healthcare workers worldwide in triaging patients, particularly in situations with limited health care resources. Furthermore, a lack of diagnosis kits and asymptomatic cases can lead to missed or delayed diagnoses, exposing visitors, medical staff, and patients to 2019-nCoV contamination. Non-clinical techniques including data mining, expert systems, machine learning, and other artificial intelligence technologies have a crucial role to play in containment and diagnosis in the COVID-19 outbreak. This study developed Enhanced Gravitational Search Optimization with a Hybrid Deep Learning Model (EGSO-HDLM) for COVID-19 diagnoses using epidemiology data. The major aim of designing the EGSO-HDLM model was the identification and classification of COVID-19 using epidemiology data. In order to examine the epidemiology data, the EGSO-HDLM model employed a hybrid convolutional neural network with a gated recurrent unit based fusion (HCNN-GRUF) model. In addition, the hyperparameter optimization of the HCNN-GRUF model was improved by the use of the EGSO algorithm, which was derived by including the concepts of cat map and the traditional GSO algorithm. The design of the EGSO algorithm helps in reducing the ergodic problem, avoiding premature convergence, and enhancing algorithm efficiency. To demonstrate the better performance of the EGSO-HDLM model, experimental validation on a benchmark dataset was performed. The simulation results ensured the enhanced performance of the EGSO-HDLM model over recent approaches. [ABSTRACT FROM AUTHOR]

The lack of interpretability in artificial intelligence models (i.e., deep learning, machine learning, and rules-based) is an obstacle to their widespread adoption in the healthcare domain. The absence of understandability and transparency frequently leads to (i) inadequate accountability and (ii) a consequent reduction in the quality of the predictive results of the models. On the other hand, the existence of interpretability in the predictions of AI models will facilitate the understanding and trust of the clinicians in these complex models. The data protection regulations worldwide emphasize the relevance of the plausibility and verifiability of AI models' predictions. In response and to take a role in tackling this challenge, we designed the interpretability-based model with algorithms that achieve human-like reasoning abilities through statistical analysis of the datasets by calculating the relative weights of the variables of the features from the medical images and the patient symptoms. The relative weights represented the importance of the variables in predictive decision-making. In addition, the relative weights were used to find the positive and negative probabilities of having the disease, which indicated high fidelity explanations. Hence, the primary goal of our model is to shed light and give insights into the prediction process of the models, as well as to explain how the model predictions have resulted. Consequently, our model contributes by demonstrating accuracy. Furthermore, two experiments on COVID-19 datasets demonstrated the effectiveness and interpretability of the new model. [ABSTRACT FROM AUTHOR]

Simple Summary: Diagnosing cancer at an early stage increases the chance of performing effective treatment in many tumour groups. Key approaches include screening patients who are at risk but have no symptoms, and rapidly and appropriately investigating those who do. Machine learning, whereby computers learn complex data patterns to make predictions, has the potential to revolutionise early cancer diagnosis. Here, we provide an overview of how such algorithms can assist doctors through analyses of routine health records, medical images, biopsy samples and blood tests to improve risk stratification and early diagnosis. Such tools will be increasingly utilised in the coming years. Improving the proportion of patients diagnosed with early-stage cancer is a key priority of the World Health Organisation. In many tumour groups, screening programmes have led to improvements in survival, but patient selection and risk stratification are key challenges. In addition, there are concerns about limited diagnostic workforces, particularly in light of the COVID-19 pandemic, placing a strain on pathology and radiology services. In this review, we discuss how artificial intelligence algorithms could assist clinicians in (1) screening asymptomatic patients at risk of cancer, (2) investigating and triaging symptomatic patients, and (3) more effectively diagnosing cancer recurrence. We provide an overview of the main artificial intelligence approaches, including historical models such as logistic regression, as well as deep learning and neural networks, and highlight their early diagnosis applications. Many data types are suitable for computational analysis, including electronic healthcare records, diagnostic images, pathology slides and peripheral blood, and we provide examples of how these data can be utilised to diagnose cancer. We also discuss the potential clinical implications for artificial intelligence algorithms, including an overview of models currently used in clinical practice. Finally, we discuss the potential limitations and pitfalls, including ethical concerns, resource demands, data security and reporting standards. [ABSTRACT FROM AUTHOR]

Accurate electricity price forecasting has become a substantial requirement since the liberalization of the electricity markets. Due to the challenging nature of electricity prices, which includes high volatility, sharp price spikes and seasonality, various types of electricity price forecasting models still compete and cannot outperform each other consistently. Neural Networks have been successfully used in machine learning problems and Recurrent Neural Networks (RNNs) have been proposed to address time-dependent learning problems. In particular, Long Short Term Memory (LSTM) and Gated Recurrent Units (GRU) are tailor-made for time series price estimation. In this paper, we propose to use multi-layer Gated Recurrent Units as a new technique for electricity price forecasting. We have trained a variety of algorithms with three-year rolling window and compared the results with the RNNs. In our experiments, three-layered GRUs outperformed all other neural network structures and state-of-the-art statistical techniques in a statistically significant manner in the Turkish day-ahead market. [ABSTRACT FROM AUTHOR]

Digital twin (DT) and artificial intelligence (AI) technologies have grown rapidly in recent years and are considered by both academia and industry to be key enablers for Industry 4.0. As a digital replica of a physical entity, the basis of DT is the infrastructure and data, the core is the algorithm and model, and the application is the software and service. The grounding of DT and AI in industrial sectors is even more dependent on the systematic and in-depth integration of domain-specific expertise. This survey comprehensively reviews over 300 manuscripts on AI-driven DT technologies of Industry 4.0 used over the past five years and summarizes their general developments and the current state of AI-integration in the fields of smart manufacturing and advanced robotics. These cover conventional sophisticated metal machining and industrial automation as well as emerging techniques, such as 3D printing and human–robot interaction/cooperation. Furthermore, advantages of AI-driven DTs in the context of sustainable development are elaborated. Practical challenges and development prospects of AI-driven DTs are discussed with a respective focus on different levels. A route for AI-integration in multiscale/fidelity DTs with multiscale/fidelity data sources in Industry 4.0 is outlined. [ABSTRACT FROM AUTHOR]

The convolutional neural network (CNN) algorithm is one of the efficient techniques to recognize hand gestures. In human–computer interaction, a human gesture is a non-verbal communication mode, as users communicate with a computer via input devices. In this article, 3D micro hand gesture recognition disparity experiments are proposed using CNN. This study includes twelve 3D micro hand motions recorded for three different subjects. The system is validated by an experiment that is implemented on twenty different subjects of different ages. The results are analysed and evaluated based on execution time, training, testing, sensitivity, specificity, positive and negative predictive value, and likelihood. The CNN training results show an accuracy as high as 100%, which present superior performance in all factors. On the other hand, the validation results average about 99% accuracy. The CNN algorithm has proven to be the most accurate classification tool for micro gesture recognition. [ABSTRACT FROM AUTHOR]